Results 231 to 240 of about 36,304 (249)
Some of the next articles are maybe not open access.

Wnt and Incretin Connections

2010
WNT signaling is emerging as a global regulator of metabolism, targeting multiple tissues. This is achieved either directly through Wnt receptors, or indirectly through the action of incretins, hormones that enhance glucose-stimulated insulin secretion and target extrapancreatic organs that cooperatively control whole body energy balance. WNT increases
openaire   +2 more sources

Incretin enhancers, incretin mimetics – from therapeutic concept to clinical application

Orvosi Hetilap, 2007
Inkretineknek az emésztőtraktus speciális sejtjeiben termelődő, peptid természetű hormonokat nevezzük, amelyek a táplálék összetevői, elsősorban szénhidrátkomponensei hatására elválasztódva, közvetett módon, összetett hatásmechanizmussal – döntően a postprandialis vércukorszint csökkentésével – részt vesznek a glükózhomeosztázis biztosításában.
openaire   +2 more sources

The Incretin Concept

1988
Publisher Summary This chapter provides an overview of incretin. According to LaBarre, incretin refers to endocrine factors from the gut with insulinotropic activity. An incretin should fulfill these conditions: (1) it must be released by nutrients, especially carbohydrates, (2) it must stimulate insulin secretion in the presence of elevated blood ...
W. Creutzfeldt, R. Ebert
openaire   +1 more source

[Incretin hormones].

Vnitrni lekarstvi, 2011
Incretin hormones are peptides that are secreted from endocrine cell of gastrointestinal tract after nutrient ingestion and stimulate insulin secretion. Glucosodependent Insulinotropic Peptide--GIP is released from K-cells of duodenum and proximal jejunum, recently GIP synthesis has been proved in pancreatic alpha cells.
openaire   +1 more source

[Incretin enhancer: sitagliptin].

Nihon rinsho. Japanese journal of clinical medicine, 2011
Recently, incretin-based therapies have become available for patients with type 2 diabetes in Japan. Sitagliptin is one of several DPP-4 inhibitors. After an OGTT, active endogenous GLP-1 concentrations are increased about twofold by sitagliptin. In clinical trials, sitagliptin was shown to be effective in monotherapy and in combination with other oral
Manabu, Kondo, Yukio, Tanizawa
openaire   +1 more source

[Incretin].

Nihon rinsho. Japanese journal of clinical medicine, 2007
Norio, Harada, Yuichiro, Yamada
openaire   +1 more source

Incretin Hormones

2008
Rémy Burcelin   +2 more
openaire   +1 more source

Incretin mimetics

Insulin, 2007
openaire   +1 more source

Incretins

RCSB Protein Data Bank
openaire   +1 more source

Incretin Therapies

The Primary Care Companion For CNS Disorders
Amre A. Elmaoued, Raechel T. White
openaire   +1 more source

Home - About - Disclaimer - Privacy